International Journal of Gynecological Cancer

The role of routine follow-up after gynecological malignancy
pp. 413-419(7)
Authors: Kew, F.M.; Roberts, A.P.; Cruickshank, D.J.

Hormone replacement therapy on ovarian and uterine cancer risk and cancer survivors: how shall we do no harm?
pp. 420-425(6)
Authors: Loizzi, V.; Cormio, G.; Vicino, M.; Fattizzi, N.; Bettocchi, S.; Selvaggi, L.

Preliminary toxicity analysis of intraperitoneal carboplatin in combination with intravenous paclitaxel chemotherapy for patients with carcinoma of the ovary, peritoneum, or fallopian tube
pp. 426-431(6)
Authors: Fujiwara, K.; Suzuki, S.; Ishikawa, H.; Oda, T.; Aotani, E.; Kohno, I.

Clear-cell cancer of the ovary—is it chemosensitive?
pp. 432-437(6)
Authors: Pather, S.; Quinn, M.A.

Quantitative biochemical analysis of lactate dehydrogenase in human ovarian tissues: correlation with tumor grade
pp. 438-444(7)
Authors: imaga,; Osmak,; Babi,; prem,; Vukeli,; Abrami,

Chemosensitivity testing of ovarian cancer using the histoculture drug response assay: sensitivity to cisplatin and clinical response
pp. 445-452(8)
Authors: Nakada, S.; Aoki, D.; Ohie, S.; Horiuchi, M.; Suzuki, N.; Kanasugi, M.; Susumu, N.; Udagawa, Y.; Nozawa, S.

Diagnostic approach using the expression profiling of the P53 tumor suppressor gene and its related proteins in ovarian epithelial tumors
pp. 453-461(9)
Authors: Lee, H.; Park, G.; Jung, J.H.; Ahn, W.S.; Lee, J.M.; Kim, B.K.; Kang,

Ultrastructure alterations in adriamycin-resistant and cisplatin-resistant human ovarian cancer cell lines exposed to nonlethal ultrasound
pp. 462-467(6)
Authors: Yu, T.; Huang, X.; Jiang, S.; Hu, K.; Kong, B.; Wang, Z.

Effect of radiotherapy on pelvic lymph node metastasis in cervical cancer stages IB2–IVA: a retrospective analysis of two comparative series
pp. 468-474(7)
Authors: Dargent, D.; Lamblin, G.; Romestaing, P.; Montbarbon, X.; Mathevet, P.; Benchaib, M.

Pelvic exenterations for gynecological malignancies: twenty-year experience at Roswell Park Cancer Institute
pp. 475-482(8)
Authors: Sharma, S.; OdunsI, K.; Driscoll, D.; Lele, S.

Comparative study of chemoradiation and neoadjuvant chemotherapy effects before radical hysterectomy in stage IB–IIB bulky cervical cancer and with tumor diameter greater than 4 cm
pp. 483-488(6)
Authors: Modarress, M.; Maghami, F.Q.; Golnavaz, M.; Behtash, N.; Mousavi, A.; Khalili, G.R.

Can we substitute brush cytology for biopsy in the evaluation of cervical lesions under the guidance of colposcopy?
pp. 489-492(4)
Authors: Eftekhar, Z.; Izadi-Mood, N.; Yarandi, F.; Khodamoradi, M.; Rahimi-Moghaddam, P.

Radioguided sentinel lymph node detection in vulvar cancer
pp. 493-497(5)
Authors: Merisio, C.; Berretta, R.; Gualdi, M.; Pultrone, D.C.; Anfuso, S.; Agnese, G.; Aprile, C.; Mereu, L.; Salamano, S.; Tateo, S.; Melpignano, M.

Outcomes of abandoned radical hysterectomy in patients with stages IB–IIA cervical cancer found to have positive nodes during the operation
pp. 498-502(5)
Authors: Suprasert, P.; Srisomboon, J.; Charoenkwan, K.; Siriaungul, S.; Khunamornpong, S.; Siriaree, S.; Phongnarisorn, C.; Lorvidhaya,

Upregulation of heat shock protein 27 in metaplastic and neoplastic lesions of the endocervix
pp. 503-509(7)
Authors: El-Ghobashy, A.A.; Shaaban, A.M.; Innes, J.; Prime, W.; Herrington, C.S.

Heterogeneity of stage IIIA endometrial carcinomas: implications for adjuvant therapy
pp. 510-516(7)
Authors: Slomovitz, B.M.; Ramondetta, L.M.; Lee, C.M.; Oh, J.C.; Eifel, P.J.; Jhingran, A.; Burke, T.W.; Gershenson, D.M.; Lu, K.H.

Abnormal cervical cytology: a risk factor for endometrial cancer recurrence
pp. 517-522(6)
Authors: Brown, A.K.; Gillis, S.; Deuel, C.; Angel, C.; Glantz, C.; Dubeshter, B.

Receptorial and mitochondrial apoptotic pathways in normal and neoplastic human endometrium
pp. 523-528(6)
Authors: Di paola, M.; Loverro, G.; Caringella, A.M.; Cormio, G.

Is aromatase cytochrome P450 involved in the pathogenesis of endometrioid endometrial cancer?
pp. 529-536(8)
Authors: Jongen, V.H.W.M.; Thijssen, J.H.H.; Hollema, H.; Donker, G.H.; Santema, J.G.; Van Der Zee, A.G.J.; Heineman,

Expression of estrogen receptors ER and ER in endometrial hyperplasia and adenocarcinoma
pp. 537-541(5)
Authors: Hu, K.; Zhong, G.; He, F.

Rectus abdominis myocutaneous flaps for neovaginal reconstruction after radical pelvic surgery
pp. 542-548(7)
Authors: Soper, J.T.; Havrilesky, L.J.; Secord, A.A.; Berchuck, A.; Clarke-Pearson, D.L

Carcinosarcoma-like mural nodule in intestinal-type mucinous ovarian of borderline malignancy: a case report
pp. 549-553(5)
Authors: Chang, W.-C.; Sheu, B.-C.; Lin, M.-C.; Chow, S.-N.; Huang,

Non-Hodgkin's lymphoma presenting as advanced ovarian cancer—a case report and review of literature
pp. 554-557(4)
Authors: Perlman, S.; Ben-Arie, A.; Feldberg, E.; Hagay,

Long-term progression-free survival of invasive uterine cervical carcinoma infected with human immunodeficiency virus: a case report
pp. 558-560(3)
Authors: Niibe, Y.; Karasawa, K.; Mizutani, K.

Intracranial metastases from adenocarcinoma of cervix: a case report
pp. 561-563(3)
Authors: Nagar, Y. S.; Shah, N.; Rawat, S.; Kataria, T.

Massive myxoid leiomyosarcoma of the uterus
pp. 564-567(4)
Authors: Vigone, A.; Giana, M.; Surico, D.; Leutner, M.; Surico,

Adenocarcinoma of mammary-like glands in the vulva successfully treated by weekly paclitaxel
pp. 568-571(4)
Authors: Tanaka, H.; Umekawa, T.; Nagao, K.; Ishihara, A.; Toyoda, N.

Colposcopy: Management options
pp. 572-572(1)
Authors: Prendiville, W.; Ritter, J.; Tatti, S.; Twiggs, L.; Bermudez, A.